Bionano Genomics Inc. (BNGO)
NASDAQ: BNGO
· Real-Time Price · USD
3.01
-0.20 (-6.23%)
At close: Aug 15, 2025, 3:01 PM
Bionano Genomics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -3.1M | -20.13M | -44.25M | -16.22M | -31.42M | -43.89M | -112.56M | -38.91M | -37.12M | -38.68M | -31.81M | -32.16M | -29.95M | -22.95M | -20.75M | -18.79M | -9.95M |
Depreciation & Amortization | 2.48M | 2.45M | 5.68M | 3.04M | 3.06M | 3.65M | 3.68M | 3.35M | 3.24M | 2.82M | 2.43M | 2.35M | 2.24M | 1.88M | 526K | 516K | 448K |
Stock-Based Compensation | 1.59M | 1.94M | 2.2M | 2.58M | 3.02M | 3.37M | 3.99M | 3.93M | 3.88M | 5.48M | 6.06M | 5.78M | 5.1M | 4.8M | 2.79M | 1.76M | 371K |
Other Working Capital | -84K | 939K | -7.13M | -4.44M | 5.03M | -873K | -4.58M | 8K | -879K | -2.59M | -81K | -477K | -814K | -44K | 547K | 3.58M | -2.09M |
Other Non-Cash Items | -5.76M | 6.97M | 21.83M | -6.01M | 782K | 24.81M | 328K | 1.34M | 915K | 799K | 302K | 573K | 677K | 1.3M | -205K | 68K | 315K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -15.94M | 77.2M | -128K | n/a | 1.76M | n/a | n/a | n/a | -6.71M | n/a | 2.08M | -1.77M |
Change in Working Capital | 2.02M | 2.27M | 1.23M | -4.36M | 5.3M | -6.25M | 1.08M | -6.27M | -3.33M | -6.7M | -6.46M | -4.87M | -10.56M | -3.95M | -2.34M | 1.95M | -3.32M |
Operating Cash Flow | -2.76M | -6.5M | -13.31M | -20.98M | -28.13M | -34.3M | -26.29M | -36.7M | -32.41M | -34.52M | -29.47M | -28.33M | -32.49M | -25.62M | -19.98M | -12.42M | -13.9M |
Capital Expenditures | n/a | n/a | n/a | -77K | -26K | -745K | -75K | -511K | -360K | -1.56M | -290K | -469K | -982K | -1.12M | -268K | -52K | -24K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | 54.63M | -33.5M | 96K | n/a | -32.04M | 693K | -31.71M | 694K | -49.09M | n/a | 126K | n/a |
Purchase of Investments | -64.77M | -18.7M | -62.74M | -41.03M | -110.56M | -106.78M | -4.49M | -96K | n/a | -20.99M | -33.67M | -14.59M | -14.95M | -108.06M | -205.33M | n/a | n/a |
Sales Maturities Of Investments | 50.7M | 21.7M | 57.36M | 69.74M | 158.17M | 52.15M | 37.99M | 29.99M | 16.89M | 65.5M | 41.91M | 46.3M | 47.18M | 66.48M | 20M | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 47.61M | -54.63M | 33.5M | 96K | n/a | 694K | -694K | 31.71M | 27K | -733K | -185.33M | 126K | n/a |
Investing Cash Flow | -14.07M | 3M | -5.38M | 28.63M | 47.59M | -55.37M | 33.43M | 29.58M | 16.53M | 11.61M | 7.95M | 31.24M | 31.96M | -92.51M | -185.6M | 74K | -24K |
Debt Repayment | -1.52M | -2.01M | -3.02M | -11.73M | -36.68M | -9.01M | -12K | -12K | -10K | -10K | -9K | -9K | -8K | 2M | n/a | -17.01M | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -910K | -817K | -1.07M | -2.41M | -386K | 66.21M | -324K | -365K | -357K | 156K | -468K | 212K | 15K | n/a | -311K | -148K | 8.9M |
Financial Cash Flow | 10.89M | 3.89M | 6.02M | -1.98M | -21.62M | 68.48M | 12.59M | 17.88M | 14.86M | 146K | 22.65M | 203K | 7K | 1.97M | 13.77M | -17.16M | 337.54M |
Net Cash Flow | -5.95M | 379K | -12.64M | 5.67M | -37.31M | 18.5M | 19.71M | 10.75M | -987K | -22.68M | 1.01M | 3.11M | -523K | -116.17M | -191.82M | -29.5M | 323.61M |
Free Cash Flow | -2.76M | -6.5M | -13.31M | -21.05M | -28.16M | -35.05M | -26.37M | -37.21M | -32.77M | -36.08M | -29.76M | -28.8M | -33.48M | -26.74M | -20.25M | -12.47M | -13.93M |